Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects

NCT04207177 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04207177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04207177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
October 30, 2019
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune suppression, kidney transplant; complications